Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

The Latest List Of Pharma Stocks With Falling Inventory Turnover Ratios (Dec-18)

|Includes:CPHI, ENDP, GlaxoSmithKline (GSK), HLF, JNJ

Screen Criteria:

All of the Pharma companies mentioned below have reported rising inventory levels, when compared to quarterly revenue growth. (Link to original post)

Ranking of This List:

This list is currently ranked 71 out of 284 lists tracked by Contextuall.com, i.e. the company characteristics described below have outperformed 75.0% of lists in Contextuall's coverage universe.

Average Weekly Returns:

Average 1-Week Return of All Stocks Mentioned Below: -3.30%

Average 1-Month Return of All Stocks Mentioned Below: 0.19%

Analysis of List Alpha:

Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Week): 1 out of 5 (20.0%)

Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Month): 3 out of 5 (60.0%)

(List sorted by monthly performance, from best to worst)

1. GlaxoSmithKline plc (NYSE:GSK): Engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. Size of inventory grew by 0.02% during the most recent quarter ($4,036M vs. $4,035M y/y), while revenue only increased by -8.12% ($6,527M vs. $7,104M y/y). Inventory, as a percentage of current assets, increased from 24.61% to 29.91% during the most recent quarter (time interval comparison 3 months ending 2012-09-30 to 3 months ending 2011-09-30).

2. China Pharma Holdings (NYSEMKT:CPHI): Develops, manufactures, and markets generic and branded pharmaceutical products primarily to hospitals and private retailers in the People's Republic of China. Size of inventory grew by 42.04% during the most recent quarter ($37.81M vs. $26.62M y/y), while revenue only increased by -41.97% ($12.18M vs. $20.99M y/y). Inventory, as a percentage of current assets, increased from 25.07% to 31.85% during the most recent quarter (time interval comparison 3 months ending 2012-09-30 to 3 months ending 2011-09-30).

3. Johnson & Johnson (NYSE:JNJ): Engages in the research and development, manufacture, and sale of various products in the health care field worldwide. Size of inventory grew by 21.48% during the most recent quarter ($7,809M vs. $6,428M y/y), while revenue only increased by 6.54% ($17,052M vs. $16,005M y/y). Inventory, as a percentage of current assets, increased from 12.03% to 17.43% during the most recent quarter (time interval comparison 3 months ending 2012-09-30 to 3 months ending 2011-10-02).

4. Herbalife Ltd. (NYSE:HLF): Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. Size of inventory grew by 40.93% during the most recent quarter ($313.58M vs. $222.5M y/y), while revenue only increased by 13.59% ($1,016.89M vs. $895.22M y/y). Inventory, as a percentage of current assets, increased from 30.32% to 33.89% during the most recent quarter (time interval comparison 3 months ending 2012-09-30 to 3 months ending 2011-09-30).

5. Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP): Operates as a specialty healthcare solutions company in the United States. Size of inventory grew by 28.74% during the most recent quarter ($363.75M vs. $282.54M y/y), while revenue only increased by -1.13% ($750.48M vs. $759.08M y/y). Inventory, as a percentage of current assets, increased from 16.85% to 21.24% during the most recent quarter (time interval comparison 3 months ending 2012-09-30 to 3 months ending 2011-09-30).

Stocks: GSK, CPHI, JNJ, HLF, ENDP